Tolfenamic acid rapid release versus sumatriptan in the acute treatment of migraine: Comparable effect in a double-blind, randomized, controlled, parallel-group study

Headache

Volumn 38, Issue 3, 1998, Pages 201-207

  Myllylä, Vilho V ^a   Havanka, Hannele ^b   Herrala, Lauri ^c   Kangasniemi, Pentti ^d   Rautakorpi, Ilkka ^e   Turkka, Jukka ^a   Vapaatalo, Heikki ^f   Eskerod, Ole ^g  

^a UNIVERSITY OF OULU   (Finland)

^b Lansi Pohja Central Hospital   (Finland)

^c KAINUU CENTRAL HOSPITAL   (Finland)

^d UNIVERSITY OF TURKU   (Finland)

^e LAPLAND CENTRAL HOSPITAL   (Finland)

^f UNIVERSITY OF HELSINKI   (Finland)

^g A/S GEA Farmaceutisk Fabrik   (Denmark)

Author keywords

Acute treatment; Migraine; Randomized controlled trial; Sumatriptan; Tolfenamic acid

Indexed keywords

PLACEBO; SUMATRIPTAN; SUMATRIPTAN SUCCINATE; TOLFENAMIC ACID;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG RESPONSE; DRUG SCREENING; DRUG TOLERABILITY; DYSURIA; FEMALE; GASTROINTESTINAL SYMPTOM; HEART PALPITATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MIGRAINE; MYALGIA; NEUROTOXICITY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TACHYCARDIA; THORAX PAIN; TREATMENT OUTCOME;

EID: 0031921795     PISSN: 00178748     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1526-4610.1998.3803201.x     Document Type: Article

References (21)

1. Silberstein SD, Lipton RB. Headache epidemiology. Emphasis on migraine. Neurol Clin. 1996;14:421-434.
2. Headache Classification Committee of the International Headache Society. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia. 1988;8(suppl 7):1-96.
3. Rasmussen BK, Olesen J. Migraine with aura and migraine without aura: an epidemiological study. Cephalalgia. 1992;12:221-228.
4. Moilanen E, Alanko J, Seppala E, Vapaatalo H. Effects of antirheumatic drugs on leukotriene B4 and prostanoid synthesis in human polymorphonuclear leukocytes in vitro. Agents Actions. 1988;24:387-394.
5. Pfaffenrath V, Scherzer S. Analgesics and NSAIDs in the treatment of the acute migraine attack. Cephalalgia. 1995;15(suppl 15):14-20.
6. Olesen J. A review of current drugs for migraine. J Neurol. 1991;238(suppl 1):S23-S27.
7. Tokola RA, Kangasniemi P, Neuvonen PJ, Tokola O. Tolfenamic acid, metoclopramide, caffeine and their combinations in the treatment of migraine attacks. Cephalalgia. 1984;4:253-263.
8. Hakkarainen H, Vapaatalo H, Gothoni G, Parantainen J. Tolfenamic acid is as effective as ergotamine during migraine attacks. Lancet. 1979;2:326-328.
9. Mikkelsen BM, Falk JV. Prophylactic treatment of migraine with tolfenamic acid. A comparative double-blind crossover study between tolfenamic acid and placebo. Acta Neurol Scand. 1982;66:105-111.
10. Mikkelsen B, Pedersen KK, Christiansen LV. Prophylactic treatment of migraine with tolfenamic acid, propranolol and placebo. Acta Neurol Scand. 1986;73:423-427.
11. Kjaersgard Rasmussen MJ, Holt Larsen B, Borg L, Soelberg Sorensen P, Hansen PE. Tolfenamic acid versus propranolol in the prophylactic treatment of migraine. Acta Neurol Scand. 1994;89:446-450.
12. Tfelt-Hansen P. Sumatriptan for the treatment of migraine attacks-a review of controlled clinical trials. Cephalalgia. 1993;13:238-244.
13. The Multinational Oral Sumatriptan and Cafergot Comparative Study Group. A randomized, double-blind comparison of Sumatriptan and Cafergot in the acute treatment of migraine. Eur Neurol. 1991;31:314-322.
14. Dechant KL, Clissold SP. Sumatriptan. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the acute treatment of migraine and cluster headache. Drugs. 1992;43:776-798.
15. The Oral Sumatriptan and Aspirin plus Metoclopramide Comparative Study Group. A study to compare oral Sumatriptan with oral aspirin plus metoclopramide in the acute treatment of migraine. Eur Neurol. 1992;32:177-184.
16. Tfelt-Hansen P, Henry P, Mulder LJ, Scheldewaert RD, Schoenen J, Chazot G. The effectiveness of combined oral lysine acetylsalicylate and metoclopramide compared with oral Sumatriptan for migraine. Lancet. 1995;346:923-926.
17. Davis CS, Chung Y. Randomization model methods for evaluating treatment efficacy in multicenter clinical trials. Biometrics. 1995;51:1163-1174.
18. Koch GG, Carr GJ, Amara IA, Stokes ME, Uryniak TJ. Categorical data analysis. In: Berry DA, ed. Statistical Methodology in the Pharmaceutical Sciences. New York: Marcel Dekker Ine; 1990:389-473.
19. Koch GG, Edwards S. Clinical efficacy trials with categorical data. In: Pearce KE, ed. Biopharmaceutical Statistics for Drug Development. New York: Marcel Dekker Inc; 1988:403-433.
20. Woolson RF. Comparing more than two groups of observations: chi-square and related procedures. In: Statistical Methods for the Analysis of Biomedical Data. Iowa City, IA: John Wiley & Sons, lnc; 1987:390-391.
21. Bousser MG, D'Allens H, Richard A. Efficacy of subcutaneous sumatriptan in the acute treatment of earlymorning migraine: a placebo-controlled trial. J Intern Med. 1993;234:211-216.